Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 2;11(9):e0162366.
doi: 10.1371/journal.pone.0162366. eCollection 2016.

Driving the Model to Its Limit: Profile Likelihood Based Model Reduction

Affiliations

Driving the Model to Its Limit: Profile Likelihood Based Model Reduction

Tim Maiwald et al. PLoS One. .

Abstract

In systems biology, one of the major tasks is to tailor model complexity to information content of the data. A useful model should describe the data and produce well-determined parameter estimates and predictions. Too small of a model will not be able to describe the data whereas a model which is too large tends to overfit measurement errors and does not provide precise predictions. Typically, the model is modified and tuned to fit the data, which often results in an oversized model. To restore the balance between model complexity and available measurements, either new data has to be gathered or the model has to be reduced. In this manuscript, we present a data-based method for reducing non-linear models. The profile likelihood is utilised to assess parameter identifiability and designate likely candidates for reduction. Parameter dependencies are analysed along profiles, providing context-dependent suggestions for the type of reduction. We discriminate four distinct scenarios, each associated with a specific model reduction strategy. Iterating the presented procedure eventually results in an identifiable model, which is capable of generating precise and testable predictions. Source code for all toy examples is provided within the freely available, open-source modelling environment Data2Dynamics based on MATLAB available at http://www.data2dynamics.org/, as well as the R packages dMod/cOde available at https://github.com/dkaschek/. Moreover, the concept is generally applicable and can readily be used with any software capable of calculating the profile likelihood.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist. Author AR received support in the form of salaries from Merrimack Pharmaceuticals. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Emergence of the Michaelis-Menten approximation.
A: Fast complex formation and decay (blue trajectories) result in the Michaelis-Menten approximation, slow formation and decay (orange trajectories) in a significant discrepancy to the data. B: The path in parameter space leading to the Michaelis-Menten approximation runs parallel to the contour lines of the log-likelihood function. C: The log-likelihood defines a significance threshold, which is not exceeded in the limit of fast formation/decay rates. Slower rates quickly lead to significant deviations from the data.
Fig 2
Fig 2. Reduction of the cascade toy model 1 (scenario 1).
A: Model scheme before (upper) and after (lower) reduction with lumped states X and pX. B: X(t) and pX(t) for fitted parameters. C: Profile likelihood for parameter k1. D: Relationship of k1 to k2 obtained by re-optimisation along the profile likelihood (panel C). E: Profile likelihood for the identifiable parameter k in the reduced model. F: ppX(t) with simulated data after fitting, with comparison between a one and two step conversion.
Fig 3
Fig 3. Reduction of the cascade toy model 2 (scenario 2).
A: Model scheme before (upper) and after (lower) reduction. The difference is the basal deactivation from pX to X with rate constant k4. B: X(t) and pX(t) with data for fitted parameters. C: Profile likelihood for parameter k4. D: Relationship of the remaining parameters to the profile shown in C. E: The reaction associated with the parameter k4 is removed by the reduction, while k5 is identifiable. F: pX(t) and X(t) with comparison before and after reduction.
Fig 4
Fig 4. Reduction through functional relation (scenario 3).
A: Model scheme before (upper) and after (lower) reduction. The difference is the removal of state Z, and the algebraic replacement pZ(t) = αpY(t). B: pY(t) and pZ(t) with simulated data after fitting. C: Profile likelihood for parameter kd,Z. D: Re-optimisation of remaining parameters along the profile likelihood for kd,Z. E: The profile likelihood for the identifiable parameter α in the reduced model. F: Comparison of trajectories for pY(t) and pZ(t).
Fig 5
Fig 5. Model reduction of weakly activated signalling pathway (scenario 4).
A: Model scheme before (upper) and after (lower) reduction. The difference is the omission of state X. B: X(t) for parameter sets along the profile likelihood of kon (high to low values of kon from bottom to top, i.e. cyan to blue). C: Parameter profile likelihood of kon, depicting a practical non-identifiability to small values. D: Relation of scale to kon. E: After model reduction, the parameter kon is structurally non-identifiable and can be set to an arbitrary value. F: Comparison of model fits before and after reduction. Both curves overlap and cannot be statistically distinguished based on the data.
Fig 6
Fig 6. Typical flow-chart for model reduction based on the profile likelihood.
The depicted steps are to be applied for each parameter individually, starting with the calculation of the respective profile likelihood. After detection, the procedure resolves non-identifiabilities by fixing parameters, removing reactions, performing algebraic substitutions, or context-specific reductions. The method terminates when all parameters of interest are identifiable.
Fig 7
Fig 7. Reelin-induced signalling pathway.
A: Scheme of the Reelin-induced signalling pathway. Sub modules that underwent model reduction are framed. B: Experimental data and model trajectories of the Reelin model. Data points and their measurement errors are shown on a log-scale for the measurements of total Dab1, phosphorylated Dab1, Akt and SFKs for time points between zero and 240 minutes. Dotted and dashed lines indicate the model response for the parameter set before and after model reduction, respectively.
Fig 8
Fig 8. Summary of model reduction steps.
A: The profile likelihood of the inhibitor release from SFKs. B: The re-optimised paths of the remaining parameters with respect to the profile of the inhibitor release. C: Parameter profile likelihood of the Akt deactivation. D: Coupling of the Akt activation, log(Aktact), to the Akt deactivation shown in panel C. E: Identifiable partitioning of SFKs with and without bound inhibitor. F: The scaling factor scalepAkt, which links the observations of pAkt to pDab1, is identifiable.

Similar articles

Cited by

References

    1. Gorban AN, Karlin IV. Method of invariant manifold for chemical kinetics. Chemical Engineering Science. 2003;58(21):4751–4768. 10.1016/j.ces.2002.12.001 - DOI
    1. Roussel MR, Fraser SJ. Invariant manifold methods for metabolic model reduction. Chaos: An Interdisciplinary Journal of Nonlinear Science. 2001;11(1):196–206. 10.1063/1.1349891 - DOI - PubMed
    1. Segel IH, Segel AH. Biochemical Calculations: How to solve mathematical Problems in General Biochemistry. Wiley; 1968.
    1. Segel LA, Slemrod M. The quasi-steady-state assumption: a case study in perturbation. SIAM Review. 1989;31(3):446–477. 10.1137/1031091 - DOI
    1. Boulier F, Lefranc M, Lemaire F, Morant PE. Model reduction of chemical reaction systems using elimination. Mathematics in Computer Science. 2011;5(3):289–301. 10.1007/s11786-011-0093-2 - DOI

Grants and funding

This work was supported by the German Ministry of Education and Research through the grants LiSyM (Grant No. 031L0048), LungSys II (Grant No. 0316042G), ReelinSys (Grant No. 0316174C), SBEpo (Grant No. 0316182B), IMOMESIC (Grant No. 031A604B). This work was also supported by the EU-IMI grant MIP-DILI (Grant No. 115336) and the DFG grant FOR1202 (TP7, Grant No. TI315/10-1). Merrimack Pharmaceuticals provided support in the form of salaries for author AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of author AR are articulated in the ‘author contributions’ section.

LinkOut - more resources